Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
375 Enhanced anti-tumor activity and T-cell fitness of 2nd-generation MAGE-A1 TCR T-cells incorporating distinct CD8 co-receptor designs
Compose a Response to This Article
Other responses
No responses have been published for this article.
